These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22752)

  • 1. Synthesis of heteroaromatic potential beta-adrenergic antagonists by the glycidol route.
    Antonio Y; Camargo C; Galeazzi E; Iriarte J; Guzman M; Muchowski JM; Gerrity K; Liu F; Miller LM; Strosberg MM
    J Med Chem; 1978 Jan; 21(1):123-6. PubMed ID: 22752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic blocking agents: substituted phenylalkanolamines. Effect of side-chain length on beta-blocking potency in vitro.
    Fuhrer W; Ostermayer F; Zimmermann M; Meier M; Müller H
    J Med Chem; 1984 Jul; 27(7):831-6. PubMed ID: 6145802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido) alkyl]amino]-2-propanols.
    Lare MS; Smith LH
    J Med Chem; 1982 Nov; 25(11):1286-92. PubMed ID: 6128420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenergic blocking agents. 20. (3-Hydroxyprop-1-enyl)-substituted 1-(aryloxy)-3-(alkylamino)propan-2-ols.
    Tucker H
    J Med Chem; 1980 Oct; 23(10):1122-6. PubMed ID: 6106716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Alkylamino-3-(2-thiazolyloxy)-2-propanols. A novel class of mixed myocardial beta-stimulants-beta-blockers.
    Edwards JA; Berkoz B; Lewis GS; Halpern O; Fried JH; Strosberg AM; Miller LM; Urich S; Liu F; Roszkowski AP
    J Med Chem; 1974 Feb; 17(2):200-3. PubMed ID: 4148933
    [No Abstract]   [Full Text] [Related]  

  • 6. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers.
    Bouzoubaa M; Leclerc G; Decker N; Schwartz J; Andermann G
    J Med Chem; 1984 Oct; 27(10):1291-4. PubMed ID: 6148422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ether derivatives of 3-amino-1,2-propanediol, II: synthesis and pharmacological investigation of n-substituted derivatives of 1-cycloalkyloxy-3-amino-2-propanols (author's transl)].
    Dantschev D; Georgiev A; Tschalina E; Dobreva-Usunova D; Staneva D
    Arch Pharm (Weinheim); 1979 Oct; 312(10):857-63. PubMed ID: 44460
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents.
    Carre MC; Youlassani A; Caubere P; Saint-Aubin-Floch A; Blanc M; Advenier C
    J Med Chem; 1984 Jun; 27(6):792-9. PubMed ID: 6145801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta 1-selective adrenoceptor antagonists. 1. Synthesis and beta-adrenergic blocking activity of a series of binary (aryloxy)propanolamines.
    Kierstead RW; Faraone A; Mennona F; Mullin J; Guthrie RW; Crowley H; Simko B; Blaber LC
    J Med Chem; 1983 Nov; 26(11):1561-9. PubMed ID: 6138434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and beta-adrenergic blocking activity of new aliphatic oxime ethers.
    Leclerc G; Bieth N; Schwartz J
    J Med Chem; 1980 Jun; 23(6):620-4. PubMed ID: 6104730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Adrenergic blocking agents. 18. 1-(Aryloxy)-3-(arylthioalkylamino)propan-2-ols and 1-substituted alkylthioamino-3-(aryloxy)propan-2-ols.
    Tucker H; Coope JF
    J Med Chem; 1978 Aug; 21(8):769-73. PubMed ID: 29123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-short-acting beta-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent.
    Erhardt PW; Woo CM; Gorczynski RJ; Anderson WG
    J Med Chem; 1982 Dec; 25(12):1402-7. PubMed ID: 6130153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
    Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
    Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
    Meyer RF; Stratton CD; Hastings SG; Corey RM
    J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
    [No Abstract]   [Full Text] [Related]  

  • 17. [Synthesis and pharmacological investigation of ether derivatives of 3-amino-1,2,-propanediol, I].
    Georgiev A; Tschalina E; Petkov W; Manolov P
    Arch Pharm (Weinheim); 1979 Nov; 312(11):881-91. PubMed ID: 44461
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
    Augstein J; Cox DA; Ham AL; Leeming PR; Snarey M
    J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
    [No Abstract]   [Full Text] [Related]  

  • 19. beta-Adrenergic blocking agents. 16. 1-(Acylaminomethyl-, ureidomethyl-, and ureidoethylphenoxy)-3-amino-2-propanols.
    Smith LH
    J Med Chem; 1977 Oct; 20(10):1254-8. PubMed ID: 20502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-adrenergic blockade by 3-[3-(substituted amino)-2-hydroxypropox]-5-hydroxybenzyl alcohols.
    Schwender CF; Pike RE; Shavel J
    J Med Chem; 1975 Feb; 18(2):211-3. PubMed ID: 235645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.